A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
about
PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastomaThe Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System TumorsA Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.Anti-Proliferative Activity of λ-Carrageenan Through the Induction of Apoptosis in Human Breast Cancer CellsTargeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibition.Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma.Novel Approaches to Apoptosis-Inducing Therapies.Cancer stem cells: The potential role of autophagy, proteolysis, and cathepsins in glioblastoma stem cells.New therapies for advanced, recurrent, and metastatic endometrial cancers.Sphingosine 1-phosphate (S1P) signaling in glioblastoma multiforme-A systematic review.Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma.Extracellular Hyaluronic Acid Influences the Efficacy of EGFR Tyrosine Kinase Inhibitors in a Biomaterial Model of Glioblastoma.The effects of PI3K-mediated signalling on glioblastoma cell behaviour.The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.Migration/Invasion of Malignant Gliomas and Implications for Therapeutic Treatment.Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs.Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells
P2860
Q26766293-84B85469-17E0-436F-980F-3976248CE451Q28087476-D179CF4A-3B0B-4B57-9AAB-F9A2D13F6C31Q35677134-BE6C0C25-166E-48D9-A136-4CAAAF52BEE3Q36351072-E0603556-8F14-40B7-8732-457073EDF7F7Q37322295-40947B69-F917-4581-87A4-B6D277027EB1Q37362875-F20FC784-001E-44A9-BFB5-317323D80243Q38759795-2E54E73A-401C-447F-9CF2-2C058F43C3D5Q38936710-A6F05754-57B9-465C-9378-1BCF8CA03B23Q39202839-8EE36312-DDA1-4105-AAF8-79393473EA6AQ47103210-C202680C-D579-4832-B19C-A689792C36C8Q47112312-55D12444-4757-4DCA-8BDB-A4920FCE4CBAQ47670776-DDBBC9E2-4BCB-4ED6-9AB6-224E175B6486Q47853903-617579A7-AF51-4277-898D-36B7E0B40E73Q47945880-9D8AEB01-2076-46B4-AE67-3C0B363C3C01Q48098509-1EA10340-BFA4-4EE8-80C5-33E0C980DF18Q52593633-51CB3E08-B1E6-4CC9-8AE0-9D7D8492C1D8Q54979176-3A1F9311-5992-43D3-A2EA-AC2D4D42AA62Q57384543-EE380575-1F0B-4D34-858F-288D9C1CFC36
P2860
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
@ast
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
@en
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
@nl
type
label
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
@ast
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
@en
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
@nl
prefLabel
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
@ast
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
@en
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
@nl
P2093
P2860
P50
P3181
P356
P1476
A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
@en
P2093
Lisa Nonnenmacher
Markus D Siegelin
Mike-Andrew Westhoff
Oliver Brühl
P2860
P2888
P3181
P356
10.1186/2052-8426-2-32
P407
P577
2014-01-01T00:00:00Z
P5875
P6179
1010034290